Cancer Modeling in Colorectal Organoids Reveals Intrinsic Differences Between Oncogenic RAS and BRAF Variants

doi 10.1101/860122
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cold Spring Harbor Laboratory

Related search

RAS and BRAF in Metastatic Colorectal Cancer Management

Journal of Gastrointestinal Oncology
OncologyGastroenterology
2016English

BRAF-mutated Metastatic Colorectal Cancer Between Past and Future

British Journal of Cancer
Cancer ResearchOncology
2015English

Oncogenic Synergism Between ErbB1, Nucleolin, and Mutant Ras

Cancer Research
Cancer ResearchOncology
2011English

BRAF Mutation as a Biomarker in Colorectal Cancer

Advances in Genomics and Genetics
2015English

Pilot Trial of Combined BRAF and EGFR Inhibition in BRAF-Mutant Metastatic Colorectal Cancer Patients

Clinical Cancer Research
Cancer ResearchOncology
2015English

Targeting Oncogenic Ras

Genes and Development
GeneticsDevelopmental Biology
2007English

Oncogenic KRAS Drives Immune Suppression in Colorectal Cancer

Cancer Cell
Cancer ResearchOncologyCell Biology
2019English

Impact of Tumour RAS/BRAF Status in a First-Line Study of Panitumumab + FOLFIRI in Patients With Metastatic Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
2016English

Mutation Pattern of KRAS and BRAF Oncogenes in Colorectal Cancer Patients

Neoplasma
Cancer Research
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy